Mark Aaron is a Cardiology physician affiliated with Saint Thomas West Hospital. OpenAlex indexes 31 publications with 3,941 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4230 Harding Rd
Suite 330
Nashville, TN 372052013
Telephone
615-269-4545Provider last certified this registry record 25 Feb 2020.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Novo Nordisk IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.4%Beta blocker15.3%Carvedilol51%Metoprolol Succinate33%Metoprolol Tartrate11%Bisoprolol Fumarate4%Atenolol1%Part D<11 patientsLoop diuretic12.4%Furosemide67%Torsemide30%Bumetanide4%Part D<11 patients+ 19 more classes in this area
Metabolism & gastrointestinal
12.5%SGLT2 inhibitor9.4%Jardiance77%Farxiga23%Part D≥120 patientsPotassium supplement2.3%Potassium Chloride100%Part D≥54 patients+ 1 more class in this area
Blood & clotting
8.1%Factor Xa inhibitor4.4%Eliquis81%Xarelto19%Part D≥53 patientsP2Y12 inhibitor2.2%Clopidogrel100%Part D≥45 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure
Journal of the American College of Cardiology
2024 - ASSESSMENT OF NEUROTENSIN RECEPTOR AGONIST EFFECTS ON FEAR-POTENTIATED STARTLE2016
Similar KOLs
Other experts from the same institution or the same specialty.
Evelio Rodriguez, MD
Saint Thomas West Hospital
Don Chomsky, MD
Saint Thomas West Hospital
Mark Tedder, MD
Saint Thomas West Hospital
Clayton Kaiser, MD
Saint Thomas West Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”